← Back to headlines
Covid vaccines, Moderna closes the lawsuit on mRNA technology: agreement for 2.25 billion
For Genevant Sciences and Arbutus Biopharma, the method used by the American giant is covered by their patent and a license would have been necessary
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Pangasinan logs lowest stunting rate in PH
just now
FG targets three million Nigerians in nationwide oral health push
just now
Health condition of Amila Zukić from Mostar is worsening: Without life-saving therapy for two months, urgent institutional reaction needed
9m ago
Lilly's next-gen weight loss therapy succeeds in late-stage trial for diabetes
10m ago